|
|
|
Air Optix® FOR ASTIGMATISM |
 |
| |
If you have astigmatism - a
subtle difference in the shape of your cornea
that can cause blurry vision - it doesn't mean
you can't see clearly, comfortably and
consistently in contact lenses.
AIR OPTIX®
for Astigmatism contact lenses offer
exceptionally stable vision and a breakthrough
design that delivers outstanding performance;
plus, outstanding comfort. |
 |
| |
| PRECISION BALANCE 8|4™
Lens Design. Keeps contact lenses in place and prevent
blurriness. |
| |
 |
 |
Because lenses for astigmatism
require two prescriptions that must stay in place relative to
the eye, stability is key to clear, consistent vision.
Some contact lenses for astigmatism rotate, which can cause
blurry vision, and the buildup of irritating deposits can make
them feel dry and less comfortable over time. AIR OPTIX® for
Astigmatism contact lenses are different. |
|
|
| |
|
|
| |
Ultra-Smooth Surface
Technology:
Creates a protective layer of moisture that
resists irritating deposits. |
|
Excellent Comfort,
Clear Vision:
For consistently comfortable and clear vision
without compromise. |
With
TriComfort™ Lens Technology, AIR OPTIX®
for Astigmatism contact lenses maintain
moisture, allow rich, nourishing oxygen to flow
continuously through the lenses, and feature an
ultra-smooth surface designed to resist deposits
delivering a healthy, natural feeling. |
| |
*AIR OPTIX® for Astigmatism (lotrafilcon B) contact lenses: High
oxygen transmissible lenses. Dk/t = 108 @ -3.00D -1.25D x 180. Ask your
eye care practitioner for complete wear, care and safety information.
Important information for AIR OPTIX® for Astigmatism (lotrafilcon B)
contact lenses: For daily wear or extended wear up to 6 nights for near/
far-sightedness and astigmatism. Risk of serious eye problems (i.e.,
corneal ulcer) is greater for extended wear. In rare cases, loss of
vision may result. Side effects like discomfort, mild burning or
stinging may occur.
AIR OPTIX, ALCON, the AIR OPTIX logo and the Alcon logo are trademarks
of Novartis AG. ©
2013 Novartis |
| |
